These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26439471)

  • 41. Matrix metalloproteinase polymorphisms are associated with bladder cancer invasiveness.
    Kader AK; Liu J; Shao L; Dinney CP; Lin J; Wang Y; Gu J; Grossman HB; Wu X
    Clin Cancer Res; 2007 May; 13(9):2614-20. PubMed ID: 17473191
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of the CYP1A1 MspI and TNFα-308 polymorphisms with chronic obstructive pulmonary disease in Inner Mongolia.
    Yang L; Li F; Yan M; Su X
    Genet Mol Res; 2014 Apr; 13(2):3209-17. PubMed ID: 24841653
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of polymorphisms in the β2-adrenergic receptor on the susceptibility and pulmonary function of patients with chronic obstructive pulmonary disease: a meta analysis.
    Niu LM; Liang Y; Xu M; Zhang YY; Zhang Y; He B
    Chin Med J (Engl); 2012 Jun; 125(12):2213-8. PubMed ID: 22884155
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Altered levels of IFN-γ, IL-4, and IL-5 depend on the
    Gutiérrez-Romero KJ; Falfán-Valencia R; Ramírez-Venegas A; Hernández-Zenteno RJ; Flores-Trujillo F; Sansores-Martínez R; Ramos-Martínez E; Pérez-Rubio G
    Front Immunol; 2024; 15():1411408. PubMed ID: 39139567
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic polymorphism in matrix metalloproteinase-9 and the susceptibility to chronic obstructive pulmonary disease in Han population of south China.
    Zhou M; Huang SG; Wan HY; Li B; Deng WW; Li M
    Chin Med J (Engl); 2004 Oct; 117(10):1481-4. PubMed ID: 15498369
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The G allele of MMP12 -82 A > G promoter polymorphism as a protective factor for COPD in Bulgarian population.
    Tacheva T; Dimov D; Aleksandrova E; Bialecka M; Gulubova M; Vlaykova T
    Arch Physiol Biochem; 2017 Dec; 123(5):371-376. PubMed ID: 28692348
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Matrix metalloproteinase circulating levels, genetic polymorphisms, and susceptibility to acute myocardial infarction among patients with coronary artery disease.
    Hlatky MA; Ashley E; Quertermous T; Boothroyd DB; Ridker P; Southwick A; Myers RM; Iribarren C; Fortmann SP; Go AS;
    Am Heart J; 2007 Dec; 154(6):1043-51. PubMed ID: 18035073
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of brain natriuretic peptide gene polymorphisms with chronic obstructive pulmonary disease complicated with pulmonary hypertension and its mechanism.
    Jin G; Chen Z; Zhang J; Song J; Shi J; Zhou B
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30217946
    [No Abstract]   [Full Text] [Related]  

  • 49. Association of gene polymorphisms of tumour necrosis factor-alpha and interleukin-13 with chronic obstructive pulmonary disease in Han nationality in Beijing.
    Jiang L; He B; Zhao MW; Ning LD; Li XY; Yao WZ
    Chin Med J (Engl); 2005 Apr; 118(7):541-7. PubMed ID: 15820084
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is MMP-7 gene polymorphism a possible risk factor for chronic obstructive pulmonary disease in Turkish patients.
    Mogulkoc U; Coskunpinar E; Aynaci E; Cağlar E; Ortakoylu MG; Ozkan G; Oltulu YM; Eraltan IY
    Genet Test Mol Biomarkers; 2012 Jun; 16(6):519-23. PubMed ID: 22417142
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polymorphisms for microsomal epoxide hydrolase and genetic susceptibility to COPD.
    Park JY; Chen L; Wadhwa N; Tockman MS
    Int J Mol Med; 2005 Mar; 15(3):443-8. PubMed ID: 15702235
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD.
    Lowrey GE; Henderson N; Blakey JD; Corne JM; Johnson SR
    Respir Med; 2008 Jun; 102(6):845-51. PubMed ID: 18328682
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Single-nucleotide polymorphisms in SMAD3 are associated with chronic obstructive pulmonary disease.
    Yang T; Ying B; Song X; Zhang S; Fan H; Xu D; Wang T; Liu D; Wen F
    Exp Biol Med (Maywood); 2010 May; 235(5):599-605. PubMed ID: 20463300
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Relationships between the expressions of intercellular adhesion molecule-1 and tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 in lung tissues of patients with chronic obstructive pulmonary disease].
    Kong YJ; Sun WX; Zhang YM; Shi YZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Feb; 31(2):129-33. PubMed ID: 18683786
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    Santiago-Ruiz L; Buendía-Roldán I; Pérez-Rubio G; Ambrocio-Ortiz E; Mejía M; Montaño M; Falfán-Valencia R
    Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31590404
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of conjugated linoleic acid on oxidative stress and matrix metalloproteinases 2 and 9 in patients with COPD.
    Matin S; Nemati A; Ghobadi H; Alipanah-Moghadam R; Rezagholizadeh L
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1449-1454. PubMed ID: 29765212
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of CYP3A4 genetic variants on the susceptibility to chronic obstructive pulmonary disease in the Hainan Han population.
    Shi H; Xu J; Feng Q; Sun J; Yang Y; Zhao J; Zhou X; Niu H; He P; Liu J; Li Q; Ding Y
    Genomics; 2020 Nov; 112(6):4399-4405. PubMed ID: 32738269
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic variation in TIMP1 but not MMPs predict excess FEV1 decline in two general population-based cohorts.
    van Diemen CC; Postma DS; Siedlinski M; Blokstra A; Smit HA; Boezen HM
    Respir Res; 2011 Apr; 12(1):57. PubMed ID: 21524282
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The matrix metalloproteinase 2-1575 gene polymorphism is associated with the risk of developing myocardial infarction in Mexican patients.
    Pérez-Hernández N; Vargas-Alarcón G; Martínez-Rodríguez N; Martínez-Ríos MA; Peña-Duque MA; Peña-Díaz Ade L; Valente-Acosta B; Posadas-Romero C; Medina A; Rodríguez-Pérez JM
    J Atheroscler Thromb; 2012; 19(8):718-27. PubMed ID: 22785600
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of proinflammatory cytokine gene polymorphisms on the risk of COPD and the levels of plasma protein.
    Ambrocio-Ortiz E; Pérez-Rubio G; Abarca-Rojano E; Montaño M; Ramos C; Hernández-Zenteno RDJ; Del Angel-Pablo AD; Reséndiz-Hernández JM; Ramírez-Venegas A; Falfán-Valencia R
    Cytokine; 2018 Nov; 111():364-370. PubMed ID: 30296713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.